Suppr超能文献

CCR5是同种异体反应性T细胞对单类II型主要组织相容性复合体不匹配的小鼠心脏移植物产生反应所必需的。

CCR5 is required for regulation of alloreactive T-cell responses to single class II MHC-mismatched murine cardiac grafts.

作者信息

Nozaki T, Rosenblum J M, Schenk A D, Ishii D, Fairchild R L

机构信息

Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

Am J Transplant. 2009 Oct;9(10):2251-61. doi: 10.1111/j.1600-6143.2009.02786.x. Epub 2009 Jul 28.

Abstract

The effector CD4 T-cell response in wild-type C57BL/6 recipients of single class II MHC-disparate B6.H-2(bm12) cardiac allografts is restricted by CD4(+)CD25(+) regulatory T cells (Tregs) resulting in long-term allograft survival. To investigate the role chemokine receptors might play in Treg function, this study tested the requirement for CCR5 on Tregs to suppress the alloimmune response in C57BL/6 recipients of B6.H-2(bm12) cardiac allografts. In contrast to the long-term survival of B6.H-2(bm12) allografts in wild-type recipients (>100 days), the allografts were acutely rejected within 25 days in CCR5(-/-) recipients with intense infiltration of CD4 T cells. Numbers and duration of donor-reactive CD4 T cells producing IFN-gamma and IL-4 were markedly increased in spleens of B6.CCR5(-/-) versus wild-type recipients. Wild-type and B6.CCR5(-/-) mice had equivalent numbers of splenic FoxP3(+) Tregs before and following transplantation, and these Tregs were equivalently suppressive in vitro. However, diminished numbers of FoxP3(+) Tregs infiltrated B6.H-2(bm12) allografts in B6.CCR5(-/-) recipients. Adoptive transfer of wild-type, but not CCR5-deficient, CD4(+)CD25(+) Tregs to CCR5(-/-) recipients restored long-term survival of B6.H-2(bm12) cardiac grafts. Collectively, these results indicate that CCR5 expression is required for the regulatory functions of Tregs that restrict alloreactive CD4 T-cell responses to single class II MHC-mismatched cardiac allografts.

摘要

在单一II类主要组织相容性复合体(MHC)不相合的B6.H-2(bm12)心脏同种异体移植的野生型C57BL/6受体中,效应性CD4 T细胞反应受到CD4(+)CD25(+)调节性T细胞(Tregs)的限制,从而导致同种异体移植长期存活。为了研究趋化因子受体在Treg功能中可能发挥的作用,本研究检测了Tregs上CCR5对于抑制B6.H-2(bm12)心脏同种异体移植的C57BL/6受体中的同种免疫反应的必要性。与野生型受体中B6.H-2(bm12)同种异体移植的长期存活(>100天)相反,CCR5基因敲除受体中的同种异体移植在25天内被急性排斥,伴有CD4 T细胞的强烈浸润。与野生型受体相比,B6.CCR5基因敲除受体脾脏中产生IFN-γ和IL-4的供体反应性CD4 T细胞的数量和持续时间显著增加。移植前后,野生型和B6.CCR5基因敲除小鼠脾脏中FoxP3(+) Treg数量相当,且这些Tregs在体外具有同等的抑制作用。然而,B6.CCR5基因敲除受体中浸润到B6.H-2(bm12)同种异体移植中的FoxP3(+) Treg数量减少。将野生型而非CCR5缺陷型的CD4(+)CD25(+) Tregs过继转移到CCR5基因敲除受体中,可恢复B6.H-2(bm12)心脏移植物的长期存活。总体而言,这些结果表明,CCR5表达对于限制对单一II类MHC不匹配心脏同种异体移植的同种反应性CD4 T细胞反应的Tregs的调节功能是必需的。

相似文献

引用本文的文献

5
Experimental glomerular endothelial injury in vivo.体内实验性肾小球内皮损伤。
PLoS One. 2013 Oct 15;8(10):e78244. doi: 10.1371/journal.pone.0078244. eCollection 2013.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验